CD19 and diffuse large B-cell lymphoma: Parks et al. note incidences of venous thrombosis embolism (VTE) in 11% (n = 4) and 7% (n = 4) in 37 DLBCL and 54 MM patients, respectively, within 60 days post-CD19 CAR T-cell infusion [13].